Toggle navigation
Home
Search
Services
Blog
Contact
About
Isolation of Novel G2 Checkpoint and Apoptotic Genes
Morgan, Susan E.
University of Illinois at Chicago, Chicago, IL, United States
Search 19 grants from Susan Morgan
Search grants from University of Illinois at Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Research Training and Education Core
A Measurement Error Approach to Estimating Usual Daily Physical Activity Distribu
Sleep Depression, and Psychosocial Risk Factors in Caregivers
Oncogene Activation During Skin Tumor Progression
Spatiotemporal Mapping of Trigeminal Evoked Potentials
Recently added grants:
Pathophysiological remodeling of the enteric neuromuscular compartment in experimental spinal cord injury
Viral Testing Core
MHC Genetic Typing Core
KCC2 and Spinal Cord Injury
Institutional Career Development Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AG005840-01
Application #
2792534
Study Section
Special Emphasis Panel (ZRG2-SSS-1 (01))
Program Officer
Lohrey, Nancy
Project Start
1999-01-31
Project End
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Related projects
NIH 1999
F32 AG
Isolation of Novel G2 Checkpoint and Apoptotic Genes
Morgan, Susan E. / University of Illinois at Chicago
NIH 1998
F32 AG
Isolation of Novel G2 Checkpoint and Apoptotic Genes
Morgan, Susan E. / University of Illinois at Chicago
Publications
Morgan, S E; Beck, W T
(2001)
Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells.
Mol Pharmacol 59:203-11
Comments
Be the first to comment on Susan Morgan's grant